Aktie A0JEGY CLINUVEL PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Clinuvel Pharmaceuticals Limited

Aktien

A0JEGY

AU000000CUV3

CUV

Markt geschlossen - Australian S.E.
Andere Börsenplätze
 08:10:45 26.04.2024 		% 5 Tage % 1. Jan.
14.57 AUD -2.80% Intraday Chart für Clinuvel Pharmaceuticals Limited +1.32% -8.94%
14.03. Clinuvel Pharmaceuticals startet Aktienrückkaufprogramm MT
14.03. CLINUVEL PHARMACEUTICALS LIMITED : Morgans Financial gibt eine Kauf-Bewertung ab ZM

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
Clinuvel Pharmaceuticals Launches Share Buyback Program
Clinuvel Pharmaceuticals Limited announces an Equity Buyback for 1,500,000 shares, representing 2.99% of its issued share capital.
Clinuvel Pharmaceuticals Limited authorizes a Buyback Plan.
Malibu shines a light on CLINUVEL’s pioneering work in photomedicine
Clinuvel Reports Positive Results in SCENESSE Study
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023
Clinuvel Pharmaceuticals Limited Announces Change to Registered Office
Clinuvel Doses First Patient in Phase 3 Trial of Vitiligo Treatment
Clinuvel Pharmaceuticals Limited Announces Board Changes
Clinuvel Pharmaceuticals Teams Up With Vitiligo Experts to Assess Scenesse
Clinuvel Pharmaceuticals Limited Announces Dividend for the Full Year Ended June 30, 2023, Payable on September 20, 2023
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Clinuvel Pharmaceuticals Secures Supply Contract for Porphyria Medication with the US Department of Veterans Affairs
Clinuvel Pharmaceuticals Secures Patents for Melanocortins for Treatment of Central Nervous System Disorders
Clinuvel Pharmaceuticals Treats First Patient in Phase Two Stroke Trial
Clinuvel Pharmaceuticals Limited Announces Technical Note - CUV803 Study and AIS
Clinuvel Pharmaceuticals Limited Announces First Stroke Patient Treated with PRENUMBRA Instant
Clinuvel Pharmaceuticals Limited Present DNA Repair Data At American Academy of Dermatology Meeting
Clinuvel Pharmaceuticals Says It Has No Deposits at Silicon Valley Bank
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0JEGY Aktie
  4. Nachrichten Clinuvel Pharmaceuticals Limited
  5. Andere Sprachen